Business
Biocon Limited Press Release Jul 07 2025
Biocon Limited has informed the Exchange regarding a press release dated July 07, 2025, titled "Biocon Biologics Receives MHRA UK Approval for Vevzuo® and Evfraxy®, Denosumab Biosimilars".
About this update from Biocon Limited
[{"type":"text","content":" Biocon Limited has informed the Exchange regarding a press release dated July 07, 2025, titled \"Biocon Biologics Receives MHRA UK Approval for Vevzuo® and Evfraxy®, Denosumab Biosimilars\". View Attachment","length":330,"tagName":"div"}]